PT  - JOURNAL ARTICLE
AU  - Anne M Kerola
AU  - Markku J Kauppi
AU  - Tuomas Kerola
AU  - Tuomo V M Nieminen
TI  - How early in the course of rheumatoid arthritis does the excess cardiovascular risk appear?
AID  - 10.1136/annrheumdis-2012-201334
DP  - 2012 Oct 01
TA  - Annals of the Rheumatic Diseases
PG  - 1606--1615
VI  - 71
IP  - 10
4099  - http://ard.bmj.com/content/71/10/1606.short
4100  - http://ard.bmj.com/content/71/10/1606.full
SO  - Ann Rheum Dis2012 Oct 01; 71
AB  - Rheumatoid arthritis (RA) is a chronic inflammatory disease which is associated with an increased cardiovascular (CV) burden. Whether the risk is already present at the time of RA diagnosis remains a key area of debate. The aim of this review was to evaluate the existence of both subclinical CV changes, including endothelial dysfunction and atherosclerosis, CV risk factors, as well as CV disease manifestations such as coronary heart disease, myocardial infarction, congestive heart failure and CV death prior to RA diagnosis and during the first few years of the disease. The state of the endothelial function remains controversial in patients with newly diagnosed RA. Studies with impaired brachial artery vasodilatory responses at baseline showed a reversal of the dysfunction after 6–12 months of anti-inflammatory therapy. Morphological evidence of arterial wall atherosclerosis, measured by carotid artery intima-media thickness or the prevalence of carotid plaques, was already present during the first year following RA diagnosis. The risk of coronary heart disease and myocardial infarction is increased even prior to and, at the latest, within 1 year of the clinical onset of RA. The prevalence of hypertension was similar among patients with RA and controls. CV mortality may not increase within the first years of RA diagnosis. In conclusion, the CV risk seems to increase sooner after the RA diagnosis than previously thought. In addition to systematic CV risk assessment, patients with early RA might benefit from being targeted with stricter than conventional CV risk prevention and intervention.